ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1673

Assessing the Feasibility of a Mediterranean-Style Diet for Patients with Rheumatoid Arthritis in a Racially and Culturally Diverse Population Across the United States

Chelsea Thompson1, iazsmin Ventura1, Cuoghi Edens2, Tamiko Katsumoto3 and Sowmya Popuri4, 1Section of Rheumatology, University of Chicago, Chicago, IL, 2Section of Pediatric Rheumatology, Section of Rheumatology, University of Chicago, Chicago, IL, 3Division of Immunology and Rheumatology, Stanford University Medical Center, Palo Alto, CA, 4Section of Internal Medicine, Loyola Medicine MacNeal, Maywood, IL

Meeting: ACR Convergence 2024

Keywords: diet, rheumatoid arthritis, socioeconomic factors, Surveys

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Abstracts: Patient Outcomes, Preferences, & Attitudes I

Session Type: Abstract Session

Session Time: 1:00PM-2:30PM

Background/Purpose: In 2023, the American College of Rheumatology published a conditional recommendation for patients living with Rheumatoid Arthritis to follow a “Mediterranean style” diet. However, patient perceptions and potential barriers to implementation of this dietary pattern remain uncharacterized. In this descriptive study, we assessed the adherence and barriers to adoption of the Mediterranean Diet in a racially, culturally, and economically diverse population living with Rheumatoid Arthritis in the United States.

Methods: An online survey was created with questions to assess baseline Mediterranean Diet Adherence Scores (MeDAS), current dietary patterns and preferences, and potential barriers to adoption of the Mediterranean Diet. The study was advertised in Rheumatology clinics across the United States as well as relevant social media accounts from partner patient advocacy organizations including the Arthritis Foundation and The Global Healthy Living Foundation.

Results: A total of 1,385 respondents with Rheumatoid Arthritis (RA) from across the United States completed the survey. Participants were primarily female (91%), from all regions of the country, and had education and income levels matching the broader US population. Most participants (56%) scored “low” on the MeDAS questionnaire. Approximately 20% of our respondents met screening criteria for food insecurity, and this was significantly associated with low MeDAS. Living in Southern and Midwestern US regions, lower education levels, lower income levels and African American race were significantly associated with lower baseline MeDAS. Self-described vegans and vegetarians had the highest MeDAS, with 27% scoring in the “high” adherence category. Spending less than 60 minutes on meal preparation daily was significantly associated with lower MeDAS. Up to 30% of respondents reported a major food aversion to one or more components of the Mediterranean Diet, with beans (30%) and whole grains (30%) representing the most disliked food categories. Although 84% of respondents were open to trying a Mediterranean style diet as a complementary treatment for their RA, only 27% of respondents reported hearing information about diet and RA from their Rheumatology provider. Those who received information about nutrition from their Rheumatology provider did not have a significantly higher MeDAS. However, those seeking and receiving information about diet and RA from patient advocacy organizations did have significantly higher MeDAS compared to those unfamiliar with these patient facing groups.

Conclusion: Although Americans living with RA from diverse backgrounds are open to additional education regarding a “Mediterranean style” diet, most do not follow this evidence-backed dietary pattern. Food insecurity and food aversions to components of the Mediterranean Diet represent major barriers to implementation. Additionally, most participants did not receive information about a Mediterranean style diet from their rheumatology provider and were not aware of the Mediterranean style diet as a complementary treatment for RA.

Supporting image 1

Mediterranean Diet Adherence Scores (MeDAS) vs Participant Demographics

Supporting image 2

Mediterranean Diet Adherence Scores (MeDAS) vs Self-Described Diet, Source of Diet Information, Preferences for Components of the Mediterranean Diet, and Food Insecurity


Disclosures: C. Thompson: None; i. Ventura: None; C. Edens: None; T. Katsumoto: Beyond Meat, 5, Sanofi, 5; S. Popuri: None.

To cite this abstract in AMA style:

Thompson C, Ventura i, Edens C, Katsumoto T, Popuri S. Assessing the Feasibility of a Mediterranean-Style Diet for Patients with Rheumatoid Arthritis in a Racially and Culturally Diverse Population Across the United States [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/assessing-the-feasibility-of-a-mediterranean-style-diet-for-patients-with-rheumatoid-arthritis-in-a-racially-and-culturally-diverse-population-across-the-united-states/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/assessing-the-feasibility-of-a-mediterranean-style-diet-for-patients-with-rheumatoid-arthritis-in-a-racially-and-culturally-diverse-population-across-the-united-states/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology